Analyst Price Target is $294.00
▲ +28.46% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for ICU Medical in the last 3 months. The average price target is $294.00, with a high forecast of $302.00 and a low forecast of $286.00. The average price target represents a 28.46% upside from the last price of $228.87.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in ICU Medical. This Buy consensus rating has held steady for over two years.
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.